health
MinSalud states there is no shortage of mental health and epilepsy medications
The most recent statement from the Ministry of Health revealed that there is currently no widespread shortage of medications for mental health and epilepsy treatments in the country.
TL;DR
- The Ministry of Health reports no widespread shortage of mental health and antiepileptic medications.
- Specific drugs like Sulpirida, Clomipramina, Atomoxetina, Clozapina, and Fenitoína are being monitored for potential supply risks.
- Potential risks are attributed to production difficulties, raw material availability, supplier issues, and commercialization interruptions.
- The Ministry clarifies that identified issues stem from management, distribution, and dispensing failures, not a lack of product or funds.
- Therapeutic alternatives and importation options are available for monitored medications to ensure treatment continuity.
- Health Promoting Entities (EPS) are obligated to guarantee timely and complete medication delivery.